Re: Trial

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

masila

Rank: Vice President [?]

Points: 818 [?]

Votes: 16 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Trial

in response to

Re: Trial

BearDownAZ

posted on Sep 19, 2016 12:38PM

Here is a good article that describes 3+3 trial designs. It seems that there are numerous variations on the theme and Zenith may even be using one of these instead of the basic 3+3 method.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684552/

masila

5 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply